Mucormycosis: early treatment is the key to survival.

Publisher: Australasian Medical Publishing Co Country of Publication: Australia NLM ID: 0400714 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1326-5377 (Electronic) Linking ISSN: 0025729X NLM ISO Abbreviation: Med J Aust Subsets: MEDLINE

Publication: : Pyrmont, NSW : Australasian Medical Publishing Co.
Original Publication: Sydney : Australasian Medical Pub. Co.

Central Nervous System Fungal Infections/*therapy ; Eye Infections, Fungal/*therapy ; Mucormycosis/*therapy ; Orbital Diseases/*therapy ; Paranasal Sinus Diseases/*therapy; Aged ; Antifungal Agents/therapeutic use ; Central Nervous System Fungal Infections/microbiology ; Central Nervous System Fungal Infections/pathology ; Diabetes Mellitus, Type 2/complications ; Eye Infections, Fungal/microbiology ; Eye Infections, Fungal/pathology ; Humans ; Immunocompromised Host ; Male ; Mucormycosis/pathology ; Necrosis ; Orbital Diseases/microbiology ; Orbital Diseases/pathology ; Paranasal Sinus Diseases/microbiology ; Paranasal Sinus Diseases/pathology ; Rhizopus oryzae/genetics ; Treatment Outcome

Cornely OA, Alastruey-Izquierdo A, Arenz D, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis 2019; 19: e405-e421.
Vaughan C, Bartolo A, Vallabh N, Leong SC. A meta-analysis of survival factors in rhino-orbital-cerebral mucormycosis-has anything changed in the past 20 years? Clin Otolaryngol 2018; 43: 1454-1464.
Prakash H, Ghosh AK, Rudramurthy SM, et al. A prospective multicenter study on mucormycosis in India: epidemiology, diagnosis, and treatment. Med Mycol 2019; 57: 395-402.
Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis 2008; 47: 503-509.
Gamba JL, Woodruff WW, Djang WT, Yeates AE. Craniofacial mucormycosis: assessment with CT. Radiology 1986; 160: 207-212.
Fanos V, Cataldi L. Amphotericin B-induced nephrotoxicity: a review. J Chemother 2000; 12: 463-470.
Saedi B, Sadeghi M, Seilani P. Endoscopic management of rhinocerebral mucormycosis with topical and intravenous amphotericin. Br J Laryngol Otol 2011; 125: 807-810.

Keywords: Diabetes complications; Immunosuppression; Mycoses; Nasal diseases; Orbital diseases

0 (Antifungal Agents)

Date Created: 20211010 Date Completed: 20211117 Latest Revision: 20211117

20240829

10.5694/mja2.51290

34628643